Many RxTrace readers have a fairly good understanding of the perspective of drug manufacturers and wholesale distributors regarding the Drug Supply Chain Security Act (DSCSA) and its implementation, but dispenser perspectives are not so well understood. Enter IQPC who interviewed Brian Files, Principal Consultant with Healthcare Strategies Consulting Group and former Director, Inventory and Compliance with CVS Health, one of the largest chain pharmacies in the US, to find out his perspectives on the DSCSA.
Many of you know Mr. Files as CVS Health’s former representative at DSCSA meetings and events over the last several years. Through his work at CVS Health, he has developed a keen understanding of the regulation and how it will likely apply to dispenser business models.
In the video below, IQPC asks Mr. Files to provide his thoughts on a number of important DSCSA topics. His dispenser perspective is made clear in his answers, which are illuminating, to say the least. People from upstream segments in the supply chain should listen carefully to his responses. Don’t dismiss what he says so quickly. From my observation, his perspective is very common among dispensers in-the-know.
The DSCSA is just one of the many topics that will be discussed at the 7th Pharma Anti-Counterfeiting and Brand Protection Summit at the Hilton Garden Inn City Center Philadelphia, PA on March 26-28, 2018. The speaker list for this event is loaded with industry veterans and technology experts. This should be a great event for anyone wanting a survey of the available anti-counterfeiting and brand protection technologies, plus you can have a one-on-one conversation with each of the experts—all under one roof. There is no better way to explore your options in a short period of time. Get the agenda and see for yourself. Don’t miss this event.